<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药前途汇 | wechat-feeds</title><link>http://MjM5NTI2NDUzNA.favicon.privacyhide.com/favicon.ico</link><description>「前途汇」通过网络和线下聚会：分享和传报全球医药行业信息资讯、技术项目、并购资源、代理品种。建立医药行业国际化的沟通桥梁、交易平台、学习园地。是中国医药行业人脉拓展、商务交流的“好圈子”。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 14 Feb 2021 11:32:17 +0800</pubDate><image><url>http://MjM5NTI2NDUzNA.favicon.privacyhide.com/favicon.ico</url><title>医药前途汇 | wechat-feeds</title><link>http://MjM5NTI2NDUzNA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>2020年中医药领域发展回顾</title><link>https://mp.weixin.qq.com/s/sDkWRxDtSf3nTqzr83UBfQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/nCWKCUtzsvwmCgLfywDb15icxI9psnc2cv6BmypOkb4siczQvumicnbTsdbQPeKC53x5pzEwevtClMNmge3393Eew/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>疾病预防及早期干预成大趋势，具有“治未病”独特优势的中医药产业迎来发展机遇。]]></content:encoded><pubDate>Sat, 13 Feb 2021 23:10:51 +0800</pubDate></item><item><title>【MAH转让】硝苯地平控释片，预BE等效</title><link>https://mp.weixin.qq.com/s/NTkOcrp5FagXbrYoPp9MXw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4MeGIJiafVufTbyibqpDVGiaK6ZZyRJG64ajoGCpNbrJVjeumhvqZ7tK9V3XIBcvvFTib5dxQzTB6wMg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>预BE等效]]></content:encoded><pubDate>Sat, 13 Feb 2021 23:10:51 +0800</pubDate></item><item><title>年终盘点 | 2020年生物医药领域融资情况</title><link>https://mp.weixin.qq.com/s/fo5eVn1AEgLisr64IlgraQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4yOrHUCoDWJnW5DnbWddYBB1LpsWjFINMVXXExxJIZE9AjPB8JnehNya4Wv5yLbyZkxZjdaktTPQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本年度国内医疗健康领域的融资交易数量达947起，交易总金额高达2087.04亿元。]]></content:encoded><pubDate>Fri, 12 Feb 2021 11:26:36 +0800</pubDate></item><item><title>【MAH转让】“雷洛昔芬片”--抗骨吸收的非激素类药物</title><link>https://mp.weixin.qq.com/s/MpKZZkIuyH4fbtziB5pfkA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4pUAJk0iaNR7qLv1ArmRILaav5XSlOneZ5aqBwdXu4Fq95L0dx7Cw7VsiaAW7LtCHde6CnLZ8ahP0g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新概念抗骨吸收的非激素类药物]]></content:encoded><pubDate>Fri, 12 Feb 2021 11:26:36 +0800</pubDate></item><item><title>冬去春来牛年到！医药项目并购和MAH交易大平台--医药前途汇携手两万多家合作伙伴7000家会员单位祝全球医药同仁新春快乐！步步高升！财源广进！阖家欢乐！</title><link>https://mp.weixin.qq.com/s/mJTpGDyPb-JaigLLzDD6fA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4dXxiawmPrvhcTZyhZE0mG5NIGCIBGI7uu5xhZDmpvg7fia53pV87T8Fyjyq5EZHQcDg9yicKCKjoQQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>冬去春来牛年到！医药项目并购和MAH交易大平台--医药前途汇携手两万多家合作伙伴7000家会员单位祝全球医药同仁新春快乐！步步高升！财源广进！阖家欢乐！]]></content:encoded><pubDate>Thu, 11 Feb 2021 09:57:54 +0800</pubDate></item><item><title>2020年生物药领域发展回顾</title><link>https://mp.weixin.qq.com/s/hvsKJeYKo0NtjoA-qBL8rA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/nCWKCUtzsvzkawIdd05jjLn9jUU0N2ticNCsmWEWzz2DNscMzoakKcuSCrcMtlrrCicSlFfye8Gbib1aDfLUcQcVw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2019年市场规模达3172亿元，未来生物药市场规模将进一步扩大。]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:34:29 +0800</pubDate></item><item><title>【MAH转让】“依帕司他片”--糖尿病并发症重磅药物</title><link>https://mp.weixin.qq.com/s/AfkZYdaNaQU6I7m_8PrHNQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4pUAJk0iaNR7qLv1ArmRILaCEngicFaJh2qgAy9h6FJueiaBv5s1wHkbySAdTRWE7J1JicV0PsKurYTA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>目前唯一一种新型醛糖还原酶（AR）抑制剂]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:34:29 +0800</pubDate></item><item><title>【MAH转让】1.2类中药，用于上呼吸道感染（Ⅲ期临床进行中）</title><link>https://mp.weixin.qq.com/s/20EBCQyX57rmNJdWZDLywg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve5qVtl54C5zfw6gHuibptvur2BoJTiamRtYzkqiaA3yv5rMcBX64HwkundM1IkyGy04icqXXJ5rI8ibp2w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>用于急性扁桃体炎、咽炎所致的咽喉疼痛、咽干的治疗。]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:34:29 +0800</pubDate></item><item><title>医药前途汇祝所有医药同仁：新年快乐！牛运亨通！财源广进！</title><link>https://mp.weixin.qq.com/s/HJWkbOYrhTBzxVS8XT0i6A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve59ibYDicLXLeiauN1icw3bCqI4R1qwCd4oQqRiaibPuUWNibUDBKAO7EHA6l24kVdsULfQh8L5CibWYmNiaMw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>冬去春来牛年到！医药项目并购和MAH交易大平台--医药前途汇携手两万多家合作伙伴7000家会员单位祝全球医药同仁新春快乐！步步高升！财源广进！阖家欢乐！]]></content:encoded><pubDate>Tue, 09 Feb 2021 15:51:38 +0800</pubDate></item><item><title>【干货分享】药品注册管理办法48个热点问题答疑</title><link>https://mp.weixin.qq.com/s/WgBD4NMHwtqqXihVa6Ns1g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4ew3tGhkQvNUJoyr4TJIkwDcXXWdLly8o4Tx24Jicm5HWF8uakwq2jJTJHydGia9biaAf66dX1KkUDA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>《药品注册管理办法》48个热点问题答疑]]></content:encoded><pubDate>Sun, 07 Feb 2021 16:16:06 +0800</pubDate></item><item><title>【MAH转让】1.1类中药临床批件，用于成人及儿童感冒发烧（Ⅱ期进行中）</title><link>https://mp.weixin.qq.com/s/0Hyaw9db1-AkNPDjgXTaNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve5qVtl54C5zfw6gHuibptvur7MIZogqeKHIib63iadL0Hiabd674WvuEa7WcQwa2qVwIibUic4edILRCdeQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>处方是在明代名医陶华《伤寒六书》所载“柴葛解肌汤”基础上加减而来]]></content:encoded><pubDate>Sun, 07 Feb 2021 16:16:06 +0800</pubDate></item><item><title>【MAH转让】“米拉贝隆缓释片”--市场巨大，仅原研1家上市</title><link>https://mp.weixin.qq.com/s/RoQ0UW_yej52sWG6FGppaw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4pUAJk0iaNR7qLv1ArmRILaDbjGdCEa6mmiaPKs0Rpa7tAn0gbxK7bkxSez3uibApWbDFib5AWRcicBuA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>该产品上市以来在全球以及中国的销量均增速迅猛，市场前景好。]]></content:encoded><pubDate>Sun, 07 Feb 2021 16:16:06 +0800</pubDate></item><item><title>【MAH转让】41个独家中药品种生产批件持有人合作</title><link>https://mp.weixin.qq.com/s/x3n2qedTBltEHY8UMZDTTA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve5QL44fAM3Rb2ZXXJwdMA2ibnywaPXNBKHBoUA8yUTaq0C6RCOiaLHfOiaEAJG2JKFQpEzEOUaeGZwkg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>近期将陆续梳理一大批可以转让持有人的“已上市药品生产批件”、“即将获批的新药技术”、“企业在研新药技术”，供医药企业家筛选合作。]]></content:encoded><pubDate>Wed, 03 Feb 2021 17:17:18 +0800</pubDate></item><item><title>【转让】儿科新药，小儿***抗感颗粒（中药1.1类，Ⅱ期进行中）</title><link>https://mp.weixin.qq.com/s/USrj_qRAJp_VOiuRZ2jA-g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve5qVtl54C5zfw6gHuibptvurfrjdlB5mJS7rb0iblXKGceeNrW2PItd3OFl4iasYiarXuvgnmPs4RR7icg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>针对小儿感冒夹痰症的有效药物。颗粒剂型，口感较好，易于小儿接受。]]></content:encoded><pubDate>Wed, 03 Feb 2021 17:17:18 +0800</pubDate></item><item><title>2020年化学药领域发展回顾</title><link>https://mp.weixin.qq.com/s/U1VGETvYlYHvcQ47Cm5tSA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/nCWKCUtzsvzqrwmoYW3JaWn6ryUzRNvChS7VUULcqiaDjm8lqLjPxLbjgicibC3jVibzclCsd8CzBUUW51lXV76wNg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>在经历了上半年的生产萎缩后，2020年下半年化学制药企业生产和经营逐渐恢复正轨。]]></content:encoded><pubDate>Wed, 03 Feb 2021 17:17:18 +0800</pubDate></item><item><title>【转让】“非布司他及片”--BE试验已开展</title><link>https://mp.weixin.qq.com/s/mfNPQO47tcbfDpyceEuvFg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve4pUAJk0iaNR7qLv1ArmRILaEyADQbwvE6hPBJrG6eYlAFGNduLgUgRXftEsCJHmfFX1183gAYicwrA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>安全性相比别嘌醇高]]></content:encoded><pubDate>Wed, 03 Feb 2021 17:17:18 +0800</pubDate></item><item><title>【邀请函】在线研讨会--药物评价在基本药物遴选中的应用</title><link>https://mp.weixin.qq.com/s/UB_ppzitkSePwwh2relMQQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve75FvzcvGMcL5VibNG8ZEc8Tc5pKwm1mRoOO6BYIAFnQpSSrHHnKAH8SYxjiatB3oIuib0Oe513f4f0A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>名额有限，限医药企业负责人、政府事务负责人。]]></content:encoded><pubDate>Tue, 02 Feb 2021 18:07:56 +0800</pubDate></item><item><title>2020年中国CDE药品申报情况盘点</title><link>https://mp.weixin.qq.com/s/QmJIEtrYuiLlFluT_t2Nxw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve75FvzcvGMcL5VibNG8ZEc8TLdmkicD48LI3SFiaOvLtKDxniav949EOqWbialaHzm7ko2Nt757IDptpqg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Mon, 01 Feb 2021 15:33:55 +0800</pubDate></item><item><title>【药学CRO】南京华威医药154个“可合作新药项目”推荐</title><link>https://mp.weixin.qq.com/s/6HO1McBq4Tr6W0J3SxYBLw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve5HlB9CkWkoLtxqDv4R4OJttVer75kXia4vs1qTzGZzsFCCwbaa111licfHPCOPTyuHZlgibXZEsoPGA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>提供从药物发现、CMC研究、注册、临床CRO、CMO/API供应等新药开发全流程的服务及一体化的解决方案。]]></content:encoded><pubDate>Mon, 01 Feb 2021 15:33:55 +0800</pubDate></item><item><title>【推荐】特色原料药及高级中间体代工基地--亿邦制药</title><link>https://mp.weixin.qq.com/s/o6wORdFqgR7yPdwYXSJfZQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/u3jpRXXEve6Q1YZqGa56w6TcEUJxzNSw0FvY1lYluHvxN3eTicJNDmm2Msf2FlrckqJstEuj9sAmj93ib8mBXY8g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>亿邦集团内创新原料药、特色原料药及高级中间体生产基地。]]></content:encoded><pubDate>Mon, 01 Feb 2021 15:33:55 +0800</pubDate></item></channel></rss>